Clinical Trials · NCT06774079
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- University of Miami
- Enrollment
- 24
- Start date
- Mar 2025
- Locations
- 1 site, United States
- Primary endpoint
- Change in percentage of participants retained